Zobrazeno 1 - 10 of 432 pro vyhledávání: '"Anti–vascular endothelial growth factor therapy"'
1
Akademický článek
Real-World Safety Outcomes with Brolucizumab in Neovascular Age-Related Macular Degeneration: Findings from the IRIS® Registry
Autor: Marco A. Zarbin, Mathew W. MacCumber, Helene Karcher, Eser Adiguzel, Andrew Mayhook, Andrew LaPrise, Ver L. Bilano, Franklin Igwe, Michael S. Ip, Charles C. Wykoff
Publikováno v: Ophthalmology and Therapy, Vol 13, Iss 5, Pp 1357-1368 (2024)
Abstract Introduction To assess real-world safety outcomes for adults with neovascular age-related macular degeneration (nAMD) treated with brolucizumab from the US-based IRIS® (Intelligent Research in Sight) Registry. Methods In this retrospective
Externí odkaz: https://doaj.org/article/4bd8e9311ca342698e41e986dba8c257
Zobrazit plný text záznamu
2
Akademický článek
Macular hole with retinal pigment epithelium tear after anti-VEGF therapy in an eye with neovascular age-related macular degeneration
Autor: Tomoko Ando, Masaomi Kubota, Tsutomu Yasukawa, Taishi Miyase, Kiyona Ishiguro, Yuya Esaki, Aki Kato, Satoko Kokuzawa, Yoshio Hirano, Hirokazu Sakaguchi
Publikováno v: American Journal of Ophthalmology Case Reports, Vol 36, Iss , Pp 102126- (2024)
Purpose: To report a case of a full-thickness macular hole (FTMH) associated with a retinal pigment epithelium (RPE) tear after anti-vascular endothelial growth factor (anti-VEGF) therapy for neovascular age-related macular degeneration (nvAMD), whic
Externí odkaz: https://doaj.org/article/ce1f6c865cdb4f89887003f7f25b9f36
Zobrazit plný text záznamu
3
Akademický článek
Case report: Sustained remission after combined sintilimab, anti-VEGF therapy, and chemotherapy in a patient with non-small cell lung cancer harboring acquired EGFR 19Del/T790M/cis-C797S mutation resistance
Autor: Wanming He, Lihua Tong, Wen Yang, Yanling Yuan, Yu Li, Wubing Tang
Publikováno v: Frontiers in Oncology, Vol 14 (2024)
Third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are highly effective against tumors harboring the T790M mutation. However, patients treated with these inhibitors ultimately develop resistance, and the most c
Externí odkaz: https://doaj.org/article/1d2b5db6ed434dcdb09fde3ecc43b3f8
Zobrazit plný text záznamu
4
Akademický článek
Three cases of macular retinal detachment exacerbated during follow-up with myopic foveoschisis around myopic choroidal neovascularization
Autor: Kaori Sayanagi, Chikako Hara, Yoko Fukushima, Shigeru Sato, Ryo Kawasaki, Kohji Nishida
Publikováno v: American Journal of Ophthalmology Case Reports, Vol 32, Iss , Pp 101899- (2023)
Purpose: Myopic choroidal neovascularization (CNV) and myopic traction maculopathy are major complications of pathologic myopia, and myopic foveoschisis (MF) is one of several symptoms that can be included under the general term “myopic traction ma
Externí odkaz: https://doaj.org/article/0ed6f29594a34a328494c649e8d07007
Zobrazit plný text záznamu
5
Akademický článek
Real-world outcomes of anti-vascular endothelial growth factor therapy for retinal vascular vein occlusion in Tibet, China
Autor: Xue-Mei Zhu, Ying-Ying Yu, Sina Zhuoga, Xiao Dawa, Yong-Kang Zhou, Ouzhu Wangmu, Deji Yangzong, Fang An, Heng Miao, Ming-Wei Zhao
Publikováno v: International Journal of Ophthalmology, Vol 15, Iss 11, Pp 1814-1820 (2022)
AIM: To evaluate the outcomes of intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents for patients with retinal vein occlusion (RVO) related-macular edema (ME) in Tibetan. METHODS: A retrospective, observational, single-center stud
Externí odkaz: https://doaj.org/article/cdf6938bf2b948318ebf99ed915287d9
Zobrazit plný text záznamu
6
Akademický článek
Prophylaxis with intraocular pressure lowering medication and glaucomatous progression in patients receiving intravitreal anti-VEGF therapy
Autor: Jeanette Du, James T Patrie, Xiao-Yu Cai, Bruce E Prum, Yevgeniy Shildkrot
Publikováno v: International Journal of Ophthalmology, Vol 15, Iss 10, Pp 1611-1618 (2022)
AIM: To investigate whether pretreatment with pressure-lowering medication prior to anti-vascular endothelial factor (VEGF) injections had an effect on glaucomatous progression in patients with preexisting glaucoma or ocular hypertension (OHT). METHO
Externí odkaz: https://doaj.org/article/c00f1d297ca64e828fca0aea821b2528
Zobrazit plný text záznamu
7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
10
Akademický článek
Treatment of neovascular age-related macular degeneration within 48 h from diagnosis improves long-term functional outcome
Autor: Raúl Martínez-Castillo, Carmen González-Gallardo, José I. Muñoz-Ávila, Pilar Font, Marta Villalba-González, Indira Stoikow, Ignacio Fernández-Choquet de Isla, Francisco Pugliese, Roberto Anaya-Alaminos, José L. García-Serrano, Francisco Hermoso-Fernández, Fabio Contieri, José E. Muñoz-de-Escalona-Rojas, Lorena Pérez-Fajardo, Mario Blanco-Blanco, Yolanda Jiménez-Gómez, Miguel González-Andrades
Publikováno v: Biomedicine & Pharmacotherapy, Vol 160, Iss , Pp 114368- (2023)
Purpose: To evaluate long-term visual and anatomical outcomes in neovascular age-related macular degeneration (nAMD) patients treated with anti-vascular endothelial growth factor (VEGF) agents depending on the time delay from confirmed diagnosis to t
Externí odkaz: https://doaj.org/article/21bcecac66084e0eb5ecba471bd36ba2
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje